Hjem › Kreft (alle typer) › Hawaii
Kliniske studier for Kreft (alle typer) i Hawaii
13 studier for Kreft (alle typer) søker deltakere på steder i Hawaii.
Byer i Hawaii
Offisiell studietekst (engelsk)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Invision, LLC, Honolulu
- University of Hawaii Cancer Center, Honolulu
- Cardiology Associates, Inc, ‘Aiea
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06989437A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Kaiser Permanente Moanalua Medical Center /ID# 238363, Honolulu
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT04928846TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- The Queen's Medical Center - POB I, Honolulu
- The Queen's Medical Center - Punchbowl, Honolulu
- The Queen's Medical Center - Kuakini, Honolulu
- og 1 flere
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT02693535Connect for Cancer Prevention Study (Connect)
- Kaiser Permanente Hawaii, Honolulu
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 30 til 70 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT04609072RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Hawaii Pacific Neuroscience, Honolulu
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07002034A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
- Univercity of Hawaii Cancer Center, Honolulu
RekruttererObservasjonsstudie
Alder 40 og eldre · Kvinner · Oppdatert 10. sep. 2026 · NCT06672302Project: Every Child for Younger Patients With Cancer
- Kapiolani Medical Center for Women and Children, Honolulu
RekruttererObservasjonsstudie
Opp til 25 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT02402244Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
- Queen's Cancer Cenrer - POB I, Honolulu
- Queen's Medical Center, Honolulu
- og 11 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT06580314EXoPERT EMERALD Clinical Study
- University of Hawaii Cancer Center, Honolulu
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 45 og eldre · Alle kjønn · Oppdatert 1. jul. 2026 · NCT07186296A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Kaiser Permanente Moanalua Medical Center /ID# 275942, Honolulu
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 8. jun. 2026 · NCT07005102Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Spark M. Matsunaga VA Medical Center, Honolulu
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 30. apr. 2026 · NCT05297734CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
- Hilo Benioff Medical Center, Hilo
- Univesity of Hawaii Cancer Center, Honolulu
- Wilcox Medical Center, Lihue
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 3. apr. 2026 · NCT06237816GEMINI-NSCLC: NSCLC Biomarker Study
- Hawaii Cancer Care, Honolulu
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 5. feb. 2026 · NCT05236114Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.